SHARE Cancer Support Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • SHARE Cancer Support's estimated annual revenue is currently $16.3M per year.(i)
  • SHARE Cancer Support's estimated revenue per employee is $243,000

Employee Data

  • SHARE Cancer Support has 67 Employees.(i)
  • SHARE Cancer Support grew their employee count by 6% last year.

SHARE Cancer Support's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.9M323%N/AN/A
#2
$13.4M5510%N/AN/A
#3
$25.4M9411%N/AN/A
#4
$78.4M26416%N/AN/A
#5
$9.3M4310%N/AN/A
#6
$51.1M17224%N/AN/A
#7
$65M2190%N/AN/A
#8
$44.8M1519%N/AN/A
#9
$6.7M31-11%N/AN/A
#10
$9.5M447%N/AN/A
Add Company

What Is SHARE Cancer Support?

SHARE is a national nonprofit that supports, educates, and empowers women affected by breast or ovarian cancer, with a special focus on medically underserved communities. SHARE meets women wherever they are with the insight of others who have been there too, creating a nationwide community where no one feels alone. Established over 40 years ago by a group of breast cancer patients and their surgeon, SHARE now offers distinct programs for women with ovarian cancer and metastatic breast cancer, and it touches lives 160,000 times each year. SHARE’s free services have been developed with insights from patients and survivors to support women of all ages, cultures, and ethnicities to make informed decisions about their care. All services are provided in both English and Spanish, and they include support groups, expert-led educational programs, national helplines, community outreach, online communities, corporate wellness programs, advocacy opportunities, caregiver support, and survivor-patient navigation.

keywords:N/A

N/A

Total Funding

67

Number of Employees

$16.3M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.1M67-7%N/A
#2
$8.2M67-21%$29.4M
#3
$9M670%N/A
#4
$8.4M67-3%N/A
#5
$9M6726%N/A